ASHP is the largest association of pharmacy professionals in the United States, representing over 65,000 pharmacists, student pharmacists, and pharmacy technicians in all patient care settings, including hospitals, ambulatory clinics, and health-system community pharmacies. For over 80 years, ASHP has championed innovation in pharmacy practice, advanced education and professional development, and served as a steadfast advocate for members and patients. In addition, ASHP is an accrediting body for pharmacy residency and technician training programs, and provides comprehensive resources to support pharmacy professionals through every stage of their careers.
Episodes
Wednesday Nov 02, 2022
Wednesday Nov 02, 2022
This session from the 2021 Midyear Clinical Meeting compares the advantages and disadvantages of continuing buprenorphine for opioid use disorder in patients with acute patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Tuesday Nov 01, 2022
Tuesday Nov 01, 2022
USP recently published final revisions to the nonsterile compounding chapter <795> and the sterile compounding chapter <797>. ASHP Senior Director of Pharmacy Practice and Quality Michael Ganio discusses the revisions, what to expect before the chapters become official, and implications for chapter <800> with compounding expert Patti Kienle.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Monday Oct 31, 2022
Monday Oct 31, 2022
This podcast focuses on lessons learned from two PGY-1 pharmacists who have both matched to a PGY-2 program. Speakers will discuss how they decided to pursue a PGY-1, how the process differs from the PGY-1 application/interview process, and ultimately how they decided where they wanted to go. This Podcast episode will help future PGY1 residents prepare for the process of identifying and applying to PGY-2 programs.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Friday Oct 28, 2022
Friday Oct 28, 2022
Faculty from our Summer Meeting symposium on COVID-19 in the immunocompromised population discuss new information and recommendation updates that have occurred since their initial presentation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Thursday Oct 27, 2022
Thursday Oct 27, 2022
In this feature from the 2021 Midyear Clinical Meeting, our content matter experts share updates from the REDUCE-IT and STRENGTH trials and the role current therapies, as well as new and emerging therapies, play in managing dyslipidemia.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Wednesday Oct 26, 2022
Wednesday Oct 26, 2022
Tom Kraus and Nick Gentile will be discussing the current state of ASHP’s advocacy priorities since our members went to Capitol Hill in mid-September. They will be discussing federal provider status, protecting the 340B program, the elimination of the X waiver, and residency funding audits.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Monday Oct 24, 2022
Monday Oct 24, 2022
This curated feature from the 2021 Midyear Clinical Meeting focuses on the impact that pharmacy technician vacancies have on pharmacy department operations and how Hartford Healthcare’s development of a yearlong internship with their local Community College created an effective pharmacy technician talent pipeline.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Saturday Oct 22, 2022
Saturday Oct 22, 2022
In this preview from the 2021 Midyear Clinical Meeting, our content matter experts will review the best practices for establishing a specialty patient management program, strategies for assessment, education, reassessment and identifying measures for a successful clinical pharmacy specialty service.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Friday Oct 21, 2022
Friday Oct 21, 2022
In this podcast we discuss the recent ruling from the Centers of Medicare and Medicaid on direct and indirect remuneration fees (DIRs). ASHP’s government relations experts and our members discuss the intent and impact of these changes for pharmacy practitioners and leaders.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Thursday Oct 20, 2022
Thursday Oct 20, 2022
Brought to you by the Section of Clinical Specialists and Scientists, this featurette from the 2021 Midyear Clinical Meeting will review the role biomarkers play in severe asthma when selecting pharmacotherapy and how to assess the place for non-biologic add on agents in severe asthma therapy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.